Sponsor Podcasts

 


Small Airways Dysfunction and COPD – the Missing Link?

Featured Saturday Break 1 and On-Demand

Speakers: Prof Bruce Thompson, Prof Greg King, Dr Li Ping Chung

Can Small Airways Dysfunction (SAD) in COPD be diagnosed and treated? Join three experts in the field of small airways in a lively discussion of the potential involvement of SAD in COPD and how this could impact clinical management in the future.

Mandatories:
Chiesi Australia Pty Ltd, Suite 3, 22 Gillman Street, Hawthorn East, VIC. 3123, Australia. Tel: +61 3 9077 4486; Fax: +61 3 8672 0792; Email: medicalaffairs.au@chiesi.com; Website: www.chiesi.com.au. Copyright © Chiesi 2021. Date of preparation: April 2021. AU-TRI-2100083

 

The Common Denominator - Type 2 Inflammation

Featured Saturday Break 4 and On-Demand

Speaker: Prof Connie Katelaris is head of the Unit of Immunology and Allergy at Campbelltown Hospital and is Professor of Immunology & Allergy at University of Western Sydney where she convenes a Masters course in Allergic Diseases. She also has a private practice at Westmead in Sydney.

This podcast was recorded on the 27th of October as part of the 2020 ADVENT asthma interactive clinical tutorial series. The full video lecture can be found on ADVENTprogram.com along with other clinical tutorials from the 2020 ADVENT Asthma series.
Prof Katelaris will discuss T2 immunity and T2 inflammation, exploring the role of type 2 inflammation in pathophysiologically related inflammatory disorders. Systemic type 2 inflammation is a unifying feature of both classic allergic respiratory diseases such as allergic rhinitis, chronic rhinosinusitis and asthma, as well as a range of other inflammatory disorders.
ADVENT is an online medical education programme dedicated to type 2 inflammatory diseases. The program is developed by world renowned experts and funded by Sanofi Genzyme and Regeneron. Access to ADVENTprogram.com is restricted to healthcare professionals.

Mandatories:
Sanofi-aventis Australia Pty ltd trading as Sanofi Genzyme, ABN 31 008 558 807.
Talavera Corporate Centre, Building D, 12–24 Talavera Road, Macquarie Park, NSW 2113. www.sanofi.com.au
MAT-AU-2100777 │Date of Preparation April 2021